The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
According to a research study published by Knowledge Sourcing Intelligence (KSI), the psycho-oncology digital health market will expand from USD 192.89 million in 2026 to USD 290.01 million in 2031 at a CAGR of 8.5% during the forecast period.
The demand for digital care solutions that provide psychological and emotional support is anticipated to see substantial growth in the market, owing to growing recognition among healthcare providers of the need to address the feelings of cancer patients.
Access sample report or view details: https://www.knowledge-sourcing.com/report/psycho-oncology-digital-health-market
Key Market Insight & Emerging Trends:
The Importance of the psycho-oncology digital health market is increasing as mental health is a key component of comprehensive cancer care today, and this is gaining traction alongside the market demand. The increasing incidence of depression, anxiety, stress, and cognitive dysfunction in cancer patients has increased the demand for easier access to personalized digital mental health solutions globally.
Digital cognitive behavioral therapy (CBT), mindfulness applications, and AI-based mental health platforms are becoming more widely used to offer ongoing emotional support, symptom management, and behavioral interventions across the continuum of cancer care. Compared with traditional face-to-face psychological services, these solutions are easier to access, and they offer better patient engagement, penetration, and scalability.
Telehealth infrastructure and the common acknowledgment of digital therapeutics have eventually fueled the market growth. Additionally, breakthroughs in artificial intelligence are creating opportunities for increasingly tailored interventions, and mobile health technologies are expanding access to care among patients located in hard-to-reach or underserved areas.
Among these regions, North America commanded the largest market share in 2025 due to significant adoption of digital therapeutics and favorable healthcare infrastructure.
Based on therapy, digital cognitive behavioral therapy (CBT) had a noteworthy share owing to its potential in managing psychological distress among cancer patients.
By indication, depression and anxiety were the dominant classes, consistent with their high burden in oncologic patients.
Based on the delivery model, mobile-based platforms accounted for the larger market share because of the growing penetration of smartphones and the rise in demand for on-the-go or remote mental health support.
Based on end user, hospitals & oncology clinics held the largest share, as these facilities integrate digital mental illness solutions into cancer care pathways.
The competitive landscape of psycho-oncology digital health is characterized by a rapidly increasing number of digital therapeutics providers, mental health technology startups, and telehealth platforms that seek to increase access to psychological care for cancer patients.
Type Insights: CBT Dominating the Market
Based on type, digital cognitive behavioral therapy (CBT) accounted for a major share of the overall market, primarily due to its rational basis and ability to provide structured psychological interventions remotely. The increasing entry of app-based CBT programs developed specifically for oncology patients is further fuelling this segment's growth.
Indication Insights: Depression and Anxiety are Driving the Demand
The two leading indication segments are depression and anxiety, as a cancer diagnosis and treatment frequently have large emotional and psychological implications. Digital mental health platforms could have the potential to provide timely support, improve emotional resilience, and result in an enhanced quality of life.
Delivery Model Insights: Care Delivery is Changing with Mobile Platforms
By solution, mobile-based solutions dominated the market owing to their convenience, ease of use, and continuous access to mental health support. Mobile platforms are becoming a more popular choice for patients, with features like symptom tracking, guided therapy sessions, meditation exercises, and AI-powered chatbots.
End User Insights: hospitals & oncology clinics maintain dominance
The market was dominated in 2025 by hospitals & oncology clinics since these segments are more aware of the need to integrate mental health support into cancer care programs. To address these challenges, many such facilities are now embracing digital psycho-oncology tools to enhance patient accessibility to psychological care and monitor patients' psychological well-being at different stages, who have the opportunity for a real-time sentinel along their treatment process.
Regional Highlights: North America Dominates while Asia Pacific Grows in Traction
North America remained the leading region in 2025, driven mainly by increasing recognition for psycho-oncology and supportive care, as well as favorable reimbursement trends for digital health technologies and the presence of key mental health technology companies. On the other hand, the Asia Pacific is anticipated to experience substantial growth throughout the assessment timeframe owing to the increasing occurrence of cancer, growing smartphone usage, and rising investments in digital healthcare infrastructure.
Competitive Landscape
The report profiles major players operating in the psycho-oncology digital health market, such as Talkspace, Inc., Akili Interactive Labs, Inc., Big Health Ltd. com, Inc., Lyra Health, Inc., Spring Health, Teladoc Health, Inc., and Twill Health. These companies are trying to focus their momentum in the psycho-oncology digital health ecosystem, such as the advancement of new AI-enabled mental healthcare solutions, tailored digital therapies, partnerships with providers for strategic expansion, and market-driven augmentation of oncology-centric mental well-being initiatives.
Market Segmentation
The report segments the psycho-oncology digital health market as follows:
By Type
Digital Cognitive Behavioral Therapy (CBT)
Mindfulness & Meditation Platforms
Psychoeducation Tools
AI-Based Mental Health Platforms
By Indication
Depression
Anxiety
Cognitive Dysfunction
Others
By Delivery Model
Mobile-Based
Web-Based
Others
By End User
Hospitals & Oncology Clinics
Specialty Mental Health Clinics
Homecare Settings
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Others
Europe
United Kingdom
Germany
Italy
France
Spain
Others
Middle East and Africa
Saudi Arabia
South Africa
Others
Asia Pacific
China
India
Japan
South Korea
Australia
Others
Companies Profiled:
Talkspace, Inc.
Akili Interactive Labs, Inc.
Big Health Ltd.
Woebot Health
Headspace Health
Calm.com, Inc.
Lyra Health, Inc.
Spring Health
Teladoc Health, Inc.
Twill Health
Explore More Reports:
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.
Palliative Care in Oncology Market is expected to reach USD 244.1 billion by 2031
The Palliative Care in Oncology Market is witnessing a steady rise due to increasing cancer cases as well as a greater emphasis on enhancing the quality of life of patients receiving treatment. Through the management of symptoms such as pain, nausea, fatigue, and psychological distress associated with cancer, palliative care also serves as a source of support for patients during their entire disease cycle. Among the factors propelling the market are the rise in the use of palliative care at an early stage, improvements in the management of pain and therapies for supportive care, and the growth of home-based care services.